drugset / Trial / NCT00080132

Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy

NCT00080132 ↗

Phase 2 Terminated 50 enrolled Medical Research Laboratories International
Open-labelTreatment

Summary

The purpose of this study is to determine if implitapide is effective in lowering triglyceride (TG) levels in patients with Fredrickson Type I or V hypertriglyceridemia where the maximum tolerable medication and diet were not sufficient.

Timeline

Start
2004-10
Primary completion
—
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Implitapide Small molecule — —

Indications